Get the Stockscreener App
0.162
4.71%
-0.008
After Hours:
.17
0.008
+4.94%
Oncology Institute Inc stock is traded at $0.162, with a volume of 1.12M.
It is down -4.71% in the last 24 hours and down -49.36% over the past month.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.
See More
Previous Close:
$0.17
Open:
$0.1722
24h Volume:
1.12M
Relative Volume:
1.07
Market Cap:
$12.24M
Revenue:
$361.07M
Net Income/Loss:
$-71.54M
P/E Ratio:
-0.1929
EPS:
-0.84
Net Cash Flow:
$-47.97M
1W Performance:
+5.19%
1M Performance:
-49.36%
6M Performance:
-64.89%
1Y Performance:
-91.24%
1-Day Range:
$0.1604
$0.178
1-Week Range:
$0.1431
$0.1991
52-Week Range:
$0.1253
$2.50
Oncology Institute Inc Stock (TOI) Company Profile
Name
Oncology Institute Inc
Sector
Industry
Phone
562-735-3226
Address
18000 STUDEBAKER RD, CERRITOS
Compare TOI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TOI
Oncology Institute Inc
|
0.162 | 12.24M | 361.07M | -71.54M | -47.97M | -0.79 |
|
HCA
Hca Healthcare Inc
|
327.22 | 82.88B | 69.62B | 5.93B | 5.88B | 22.27 |
|
THC
Tenet Healthcare Corp
|
142.68 | 13.94B | 20.97B | 3.13B | 2.39B | 31.21 |
|
DVA
Davita Inc
|
166.17 | 13.63B | 12.67B | 827.68M | 1.42B | 9.27 |
|
UHS
Universal Health Services Inc
|
205.00 | 13.52B | 15.42B | 1.03B | 956.84M | 15.02 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.02 | 12.92B | 20.87B | 715.14M | 1.67B | 1.2209 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-24 | Resumed | Jefferies | Buy |
| Sep-14-22 | Initiated | Guggenheim | Buy |
| Aug-15-22 | Initiated | Jefferies | Buy |
Oncology Institute Inc Stock (TOI) Latest News
Despite Recent Gains, Oncology Institute Insiders Are Still Down US$110k - Simply Wall St
Grapevine Saves The Oncology Institute Millions On Healthcare Supplies - Markets Insider
Oncology Institute Inc (NASDAQ: TOI): Blank Check For Growth? - Stocks Register
Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx's Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial - The Manila Times
Oncology Institute Third Quarter 2024 Earnings: US$0.21 loss per share (vs US$0.19 loss in 3Q 2023) - Yahoo Finance
The Oncology Institute, Inc. (NASDAQ:TOI) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: The Oncology Institute reports strong growth in Q3 2024 - Investing.com
Oncology Institute Reports Strong Revenue Growth Amid Challenges - TipRanks
The Oncology Institute, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
The Oncology Institute Reports Third Quarter 2024 Financial Results - The Manila Times
Oncology Institute Q3 Revenue Jumps 22% to $99.9M Despite Margin Pressure | TOI Stock News - StockTitan
Oncology Institute Announces Board Changes for 2025 - TipRanks
Repare Therapeutics Announces Agreement with the US National Cancer Institute to Advance the Development of Camonsertib - BioSpace
The Oncology Institute Announces Certification to Administer Pluvicto Therapy in California - The Manila Times
Oncology Institute (TOI) Launches Groundbreaking Outpatient Cancer Treatment Service | TOI Stock News - StockTitan
The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call - ForexTV.com
Cancer Care - WellSpan Health
Bayhealth welcomes new hematologist oncologist to cancer institute - CapeGazette.com
GlycoMimetics Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint - Business Wire
The Oncology Institute Joins Lantern's Cancer Care Network of Excellence - The Manila Times
The Oncology Institute Joins Lantern’s Cancer Care Network of Excellence - GlobeNewswire
Steven K. Libutti, MD, FACS, Named Inaugural William N. Hait Director at Rutgers Cancer Institute - RWJBarnabas Health
The American Journal of Managed Care® and The Oncology - GlobeNewswire
The American Journal of Managed Care® and The Oncology Institute to Co-Host Symposium for Value-Based Cancer Care - StockTitan
US FDA issues Study May Proceed letter for the Pilot Study of Pidnarulex Pharmacodynamics in Patients with Advanced Solid Tumors, Sponsored by the US National Cancer Institute - PR Newswire
Verismo Therapeutics Announces the Activation of its CELESTIAL-301 Clinical Trial at Colorado Blood Cancer Institute - PR Newswire
TOIIWThe Oncology Institute, Inc. Warrant Latest Stock News & Market Updates - StockTitan
The Oncology Institute of Hope & Innovation Launches Oregon Market - GlobeNewswire
IGI Announces CRADA with National Cancer Institute to Test - GlobeNewswire
Cancer Care | Plantation - Baptist Health South Florida
The Oncology Institute Announces CFO Changes - Marketscreener.com
Logos Global Management LP Takes $14.30 Million Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
Promising Progress in Oncology as Cancer Deaths Decline and Research Grows - Baystreet.ca
Nomic® and Parker Institute for Cancer Immunotherapy (PICI) Launch Large-Scale Protein Profiling to Investigate Immunotherapy Responses in RADIOHEAD Study - Business Wire
Farallon Capital Management LLC Sells 729,200 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - MarketBeat
The Oncology Institute announces chief financial officer transition - Yahoo Finance
Circassia Pharmaceuticals Announces Share Buyback - TipRanks
Circassia Pharmaceuticals Announces Strong H1 2024 Results - TipRanks
Indian Oil Corp. shares up 0.76% as Nifty gains - The Economic Times
The Oncology Institute appoints new CFO - Investing.com
Oncology Institute Announces CFO Transition and Strategic Growth Plan - TipRanks
The Oncology Institute Announces CFO Transition - GlobeNewswire
Cardinal Health to acquire Integrated Oncology Network for $1.12B - HealthLeaders Media
Ionis Plans $500M Public Offering - San Diego Business Journal
Itau Unibanco Holding S.A. Buys Shares of 767 Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
Renaissance Technologies LLC Purchases 69,800 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
ORIX Co. (NYSE:IX) Shares Purchased by American Century Companies Inc. - Defense World
The Oncology Institute, Inc Announces CFO Transition - Investing.com
DRW Securities LLC Makes New $2.43 Million Investment in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - MarketBeat
Victory Capital Management Inc. Sells 307 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
The Oncology Institute, Inc. (TOI) Reports Q2 Loss, Misses Revenue Estimates - MSN
Oncology Institute Inc Stock (TOI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.57%
0.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):